Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Medesis Pharma and CEA sign collaborative agreement

April 3, 2014

Southwest Research Institute receives contract extension for cyanide antidote

March 31, 2014

New monoclonal antibodies for the treatment of botulism disclosed

March 24, 2014

MediciNova announces start of MN-166 clinical study for marijuana dependence

March 11, 2014

Titan Pharmaceuticals and FDA discuss path forward for Probuphine

March 4, 2014

Humanetics and USAMRICD enter into CRADA to study BIO-300 to treat phosgene exposure

Feb. 26, 2014

FDA clears path for smoking cessation trial of INV-102

Jan. 30, 2014

Phase I study of novel treatment candidate for alcoholism begins patient recruitment

Jan. 27, 2014

FDA grants orphan drug status to Aeolus' drug candidate for treatment of acute radiation syndrome

Jan. 24, 2014

Neumedicines' HemaMax shown to improve survival outcomes following lethal irradiation

Jan. 10, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...